Last updated: October 26, 2023
Sponsor: Europainclinics z.ú.
Overall Status: Active - Recruiting
Phase
N/A
Condition
Occlusions
Treatment
lumbar sympathetic blockade
Clinical Study ID
NCT06111599
4/2023/VUSCH/EK
Ages 20-80 All Genders
Study Summary
Eligibility Criteria
Inclusion
Inclusion Criteria:
- Chronic limb-threatening ischemia-Patients with chronic leg pain for at least 6 monthswith intensity (VAS >=5)
- those who (only if a signature was obtainable), or whose legal guardian,fullyunderstood the clinical trial -details and signed the informed consent form
Exclusion
Exclusion Criteria:
- Chronic Venous Insufficiency
- women with positive a pregnancy tests before the trial or who planned to becomepregnant within the following 3 years
- other patients viewed as inappropriate by the staff
- disagreement with participation in the study
Study Design
Total Participants: 60
Treatment Group(s): 1
Primary Treatment: lumbar sympathetic blockade
Phase:
Study Start date:
October 22, 2023
Estimated Completion Date:
August 31, 2026
Study Description
Connect with a study center
Europainclinics
Košice, 04011
SlovakiaActive - Recruiting
Not the study for you?
Let us help you find the best match. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.